FellowshipIntensive venture capital training for life sciences graduates.

Forbion is a global venture capital firm specializing in life sciences, managing over €5 billion across multiple funds. It focuses on investing in innovative biotech companies addressing human health and environmental challenges.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Forbion is a global venture capital firm founded in the 1990s, originally as ABN AMRO Capital Life Sciences, and rebranded to Forbion Capital Partners in 2006, later streamlined to Forbion in 2018. The firm is based in the Netherlands, Germany, and the United States, and manages over €5 billion across multiple fund strategies that cover all stages of (bio-)pharmaceutical drug development. Forbion focuses on advancing biotech innovations in human health and addressing planetary health challenges through its BioEconomy fund strategy. The firm invests in innovative biotech companies across various sectors, including human health and planetary health, with key areas of interest including immunology, oncology, and rare diseases.
Forbion invests in innovative biotech companies across various sectors, focusing on human health and planetary health. Its Human Health strategy supports biopharmaceutical companies addressing unmet medical needs through seed funding, company building, and expansion. Key areas of interest include immunology, cardiovascular/metabolic diseases, central nervous system disorders, oncology, and rare diseases. The BioEconomy strategy emphasizes sustainable solutions in food, agriculture, materials, and environmental technologies.
Forbion adds value to its portfolio companies through strategic support in funding, company building, and access to a vast network of industry experts and resources, enhancing their potential for growth and innovation.
Forbion focuses on innovative biotech companies that address unmet medical needs and sustainable solutions. The firm invests across various stages, including seed, seed-plus, series A, and growth equity.
Founders can pitch to Forbion by visiting their website at forbion.com or by emailing info@forbion.com. A detailed pitch deck should be included, outlining the business model, market opportunity, and team background.
Forbion's unique focus on both human health and planetary health sets it apart. The firm emphasizes sustainable solutions through its BioEconomy strategy, targeting advancements in food, agriculture, and environmental technologies.
Forbion operates globally, with a strong presence in North America and Europe. The firm has offices in the Netherlands, Germany, and the United States, allowing it to engage with a diverse range of startups.
Forbion adds value to its portfolio companies through strategic support in company building, seed funding, and expansion efforts. The firm leverages its extensive network and expertise in the biotech sector to assist its portfolio companies.
Forbion's check sizes vary depending on the stage of investment, covering seed, seed-plus, series A, and growth equity stages. Specific amounts are tailored to the needs of the portfolio companies.
Superscout Pro
Is this page right?Reviewed · How the research works